CONSULTANT PHARMACIST最新文献_第4页

Hyponatremia Induced by Duloxetine: A Case Report. 度洛西汀致低钠血症1例。

CONSULTANT PHARMACIST Pub Date : 2018-08-01 DOI: 10.4140/TCP.n.2018.446

Daniel Hu, Sarah Wurster

引用次数: 4

How Are We Doing? Mid-Year Checkup. 我们做得怎么样?年中检查。

CONSULTANT PHARMACIST Pub Date : 2018-08-01 DOI: 10.4140/TCP.n.2018.468

Paul Baldwin

引用次数: 0

A Review of Cranberry Use for Preventing Urinary Tract Infections in Older Adults. 蔓越莓预防老年人尿路感染的研究综述。

CONSULTANT PHARMACIST Pub Date : 2018-08-01 DOI: 10.4140/TCP.n.2018.450

Tiana Luczak, Michael Swanoski

引用次数: 2

Therapy for Open-Angle Glaucoma. 开角型青光眼的治疗。

CONSULTANT PHARMACIST Pub Date : 2018-08-01 DOI: 10.4140/TCP.n.2018.432

Leisa L Marshall, Renée L Hayslett, Gregg A Stevens

{"title":"Therapy for Open-Angle Glaucoma.","authors":"Leisa L Marshall, Renée L Hayslett, Gregg A Stevens","doi":"10.4140/TCP.n.2018.432","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.432","url":null,"abstract":"Objective: Review the clinical manifestations and treatment of primary open-angle glaucoma (POAG).Data sources: Articles indexed in PubMed, Scopus, and Cochrane Library in the last 10 years using the key words \"glaucoma,\" \"open-angle glaucoma,\" and \"'open-angle glaucoma' AND 'treatment.'\" Primary sources were used to locate additional resources. ClinicalTrials. gov was used to locate unpublished studies.Study selection and data extraction: Eighty-one publications were reviewed and criteria supporting the primary objective were used to identify useful resources.Data synthesis: The literature included practice guidelines, review articles, original research articles, and product prescribing information for POAG.Conclusion: The POAG optic neuropathies result in optic disk damage and visual field loss. Ophthalmic medication therapy retards glaucoma progression, but many older patients require multiple medications to preserve vision and quality of life. An agent from the ophthalmic prostaglandin analog class is used as initial therapy in current practice because of the convenience of once-a-day administration and lower incidence of systemic side effects and slightly increased efficacy compared with other available ophthalmic medication classes. The other ophthalmic medication classes used in clinical practice include the beta-adrenergic blocking agents, the alpha-2 adrenergic agonists, and the carbonic anhydrase inhibitors. Proper ophthalmic eye-drop administration and medication adherence are imperative for preserving vision in POAG. Selective laser trabeculoplasty is a viable alternative to ophthalmic medications either initially or if a patient experiences ocular or systemic side effects from medication therapy. A modified prostaglandin analog was approved by the Food and Drug Administration in November 2017; its role in clinical practice is still evolving.","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":"33 8","pages":"432-445"},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4140/TCP.n.2018.432","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36364541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 10

Pharmacists Focus on Adapting for the Future. 药剂师注重适应未来。

CONSULTANT PHARMACIST Pub Date : 2018-08-01 DOI: 10.4140/TCP.n.2018.414

Joanne Kaldy

引用次数: 0

Communicating for Drug Safety. 沟通促进药品安全。

CONSULTANT PHARMACIST Pub Date : 2018-08-01 DOI: 10.4140/TCP.n.2018.406

H Edward Davidson

引用次数: 1

Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients. 门诊老年患者用药错误和不良事件的发生率及可预防性。

CONSULTANT PHARMACIST Pub Date : 2018-08-01 DOI: 10.4140/TCP.n.2018.454

Shirley H Díaz Hernández, Iadelisse Cruz-Gonzalez

{"title":"Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients.","authors":"Shirley H Díaz Hernández, Iadelisse Cruz-Gonzalez","doi":"10.4140/TCP.n.2018.454","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.454","url":null,"abstract":"Objective: To assess the incidence of medication errors, adverse drug events (ADEs), and potential ADEs (poADEs) in patients 65 years of age and older.Design: This is a retrospective cohort study (2011 to 2014).Setting: The study was performed at a section 330 federally funded ambulatory health care center.Patients: The study was a convenience sample selected in a nonrandomized way from event reports filed in those years.Intervention: Data were collected through event reports and medical record review. Descriptive statistics and chi-square were employed to analyze data.Results: During the study period, at least one medication error, poADE, or ADE report was documented in 170 out of 2,218 older patients (incidence: 12.5, 9.4, and 5.0 per 100 patient-years, respectively); 42.9% of ADEs were preventable. The chronic conditions most frequently related to ADEs were diabetes (18%), hypertension (18%), and hyperlipidemia (12%). The use of hypoglycemic agents was commonly associated with ADEs (14%; P = 0.001). An increased number of prescribed medications were significantly associated with all the adverse events.Conclusions: Medication errors, poADEs, and ADEs are common in patients 65 years of age or older taking more than three medications. Almost half of the detected ADEs were preventable.","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":"33 8","pages":"454-466"},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4140/TCP.n.2018.454","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36364544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 13

Perceptions of Nursing Facility Providers on the Utility of Deprescribing. 护理机构提供者对处方解除效用的看法。

CONSULTANT PHARMACIST Pub Date : 2018-07-01 DOI: 10.4140/TCP.n.2018.386

Jennifer Pruskowski, Barbara J Zarowitz, Steven M Handler

{"title":"Perceptions of Nursing Facility Providers on the Utility of Deprescribing.","authors":"Jennifer Pruskowski, Barbara J Zarowitz, Steven M Handler","doi":"10.4140/TCP.n.2018.386","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.386","url":null,"abstract":"Objective: Potentially inappropriate medications carry significant burden and costs to nursing facility residents and health systems. The goal of this study was to survey nursing facility providers from across the United States to describe the current utilization of deprescribing, and perceptions and desired components of a deprescribing program, in nursing facilities to reduce potentially inappropriate medications.Design/setting/participants/measurement: We surveyed health care providers who attended the 2017 AMDA-The Society for Post-Acute and Long-Term Care Medicine Annual Conference-in Phoenix, Arizona. Returned surveys were entered into an electronic database from paper copies. Survey responses were summarized using descriptive statistics.Results: Of the 1,431 conference attendees, 637 surveys were returned for a 45% response rate. Most respondents were physicians (n = 563, 88%). Respondents indicated a strong agreement with the potential for deprescribing to reduce cost to residents and nursing administration time and burden, while disagreeing that deprescribing may be depersonalizing. Respondents indicated clear preference for deprescribing programs to target medications that are no longer indicated and are \"high risk,\" and that such programs should include discussions with the resident. Respondents also agreed that deprescribing programs are successful if the resident, or the resident's family and/or caregivers, reports an improvement in quality of life.Conclusion: Among respondents there was a high degree of confidence in the potential impact of deprescribing initiatives, as well as a broad consensus of desired components. This information may increase consultant pharmacist engagement and drive future proactive deprescribing initiatives.","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":"33 7","pages":"386-402"},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4140/TCP.n.2018.386","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36304771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Interventions to Improve Medication Adherence in Older Adults With Cognitive Impairment. 改善老年认知障碍患者药物依从性的干预措施。

CONSULTANT PHARMACIST Pub Date : 2018-07-01 DOI: 10.4140/TCP.n.2018.382

Soyoung Park, Zachary A Marcum

引用次数: 0

CMS Unveils Latest Payment Model for Nursing Facilities. CMS公布了护理机构的最新支付模式。

CONSULTANT PHARMACIST Pub Date : 2018-07-01 DOI: 10.4140/TCP.n.2018.404

Paul Baldwin

引用次数: 0